LOOMINGTON, Ind.–(BUSINESS WIRE)–Today, Cook Medical announced Dan Kaiser as the leader of global research and development (R&D). This dedicated engineering team will connect product development more closely to customer needs and accelerate the process of getting new products to market. “Our R&D team has been reorganized under a global structure […]
Other News
At ACC, Siemens Healthineers Introduces a Portable Cardiovascular-Dedicated Ultrasound System
ORLANDO, Fla.–(BUSINESS WIRE)– ACC 2018: Booth #3127— At the American College of Cardiology’s 67th Annual Scientific Session and Expo, Siemens Healthineers launched its new portable cardiovascular ultrasound solution, the ACUSON Bonsai. According to a recent study, 34 million echo exams were performed in the U.S. in 2017.1 The ACUSON Bonsai addresses the challenge of these […]
Baylis Medical wins Best Managed Companies award
TORONTO, March 8, 2018 /PRNewswire/ – Baylis Medical Company is proud to announce that it has been named a 2018 winner of Canada’s Best Managed Companies, one of the country’s leading business award programs honouring excellence in Canadian-owned and managed businesses. Established in 1993, Canada’s Best Managed Companies recognizes those that demonstrate […]
Marketwired: Mar 08, 2018 — Novoheart’s Landmark, Peer-Reviewed Study Published, Recognizing the Effectiveness of the World’s First and Only Human Heart-in-a-Jar
VANCOUVER, BRITISH COLUMBIA — (Marketwired) — Mar 08, 2018 — Novoheart (“Novoheart” or the “Company”) (TSX VENTURE: NVH)(FRANKFURT: 3NH) is pleased to announce that it has published a comprehensive study of the world’s first human heart-in-a-jar, in the prestigious bioengineering journal Biomaterials. The peer-reviewed paper showcases the human heart-in-a-jar’s unique ability to recapitulate […]
CryoLife Reports Fourth Quarter and Full Year 2017 Results
ATLANTA, March 7, 2018 /PRNewswire/ — Fourth Quarter and Recent Business Highlights: Achieved fourth quarter revenues of $52.8 million Achieved double digit revenue growth on a percentage basis in BioGlue®, On-X, and tissue processing Recorded GAAP net loss of ($3.0) million, or ($0.09) per fully diluted common share; Non-GAAP net income of $4.0 million, or $0.11 per fully diluted […]
Cardiac Resynchronization Therapy Systems Market Expected to Reach USD 4.9 Bn Globally in 2025; Says TMR
ALBANY, New York, March 8, 2018 /PRNewswire/ — The global Cardiac Resynchronization Therapy Systems market was valued at approximately US$ 3.1 Bn in 2016 is projected to register cumulative annual growth rate (CAGR) of over 5.3% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Cardiac Resynchronization […]
Saranas’ Novel Bleed Monitoring System Receives Recognition in Cardiovascular Research Technologies 2018 Competition
HOUSTON–(BUSINESS WIRE)– Saranas, a medical device company with a cutting-edge technology for real-time detection and monitoring of internal bleeding during endovascular procedures, placed first runner-up at the Cardiovascular Research Technologies (CRT) competition on March 6, 2018, in Washington, D.C. “We are extremely honored that our Early Bird™ Bleed Monitoring System has been recognized […]
LivaNova Enters into Definitive Agreement to Divest Its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation
LONDON–(BUSINESS WIRE)– LivaNova PLC (NASDAQ:LIVN) (“LivaNova”) today announced that it has entered into a definitive Stock and Asset Purchase Agreement (“Purchase Agreement”) to divest its Cardiac Rhythm Management business franchise to MicroPort Scientific Corporation (“MicroPort”). LivaNova and MicroPort executed and delivered the Purchase Agreement, pursuant to the terms of a binding Letter of Intent, […]
New Prevencio Study Using AI Demonstrates Simple Blood Test Accurately Diagnoses Aortic Stenosis
KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc., today announces its HARTTM AS multi-protein, artificial intelligence (AI)-driven test, which data indicates accurately diagnoses Aortic Stenosis (AS)—a condition with a 50 percent death rate when left untreated. AS is the most common valvular heart disease in the Western world, present in more than 20 percent of […]
EBR Systems, Inc. Initiates Global Trial of World’s Only Wireless CRT Pacing Technology
SUNNYVALE, Calif.–(BUSINESS WIRE)–EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced enrollment of the first patients in the global SOLVE-CRT (Stimulation of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy) clinical trial. The first patients were enrolled by Prof. Dr. Christian Butter […]



